Literature DB >> 4009158

New data from the Addiction Severity Index. Reliability and validity in three centers.

A T McLellan, L Luborsky, J Cacciola, J Griffith, F Evans, H L Barr, C P O'Brien.   

Abstract

The Addiction Severity Index (ASI) is a clinical/research instrument which has been in wide use during the past 6 years to assess the treatment problems found in alcohol- and drug-abusing patients. In a study of male veterans, a preliminary evaluation of the ASI has indicated reliability and validity. The present report presents an expanded examination of these issues; 181 subjects from three treatment centers were studied. Results of concurrent reliability studies indicate that trained technicians can estimate the severity of patients' treatment problems with an average concordance of .89. Test-retest studies show that the information obtained from the ASI is consistent over a 3-day interval, even with different interviewers. Comparisons of the ASI severity ratings and composite measures with a battery of previously validated tests indicate evidence of concurrent and discriminant validity. The reliability and validity results were consistent across subgroups of patients categorized by age, race, sex, primary drug problem, and treatment center. The authors discuss the strengths and limitations of the instrument based upon 5 years of use. The overall conclusion is that the ASI is a reliable and valid instrument that has a wide range of clinical and research applications, and that it may offer advantages in the examination of important issues such as the prediction of treatment outcome, the comparison of different forms of treatment, and the "matching" of patients to treatments.

Entities:  

Mesh:

Year:  1985        PMID: 4009158     DOI: 10.1097/00005053-198507000-00005

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  388 in total

1.  Name-based reporting of HIV-positive test results as a deterrent to testing.

Authors:  W J Woods; J W Dilley; T Lihatsh; J Sabatino; B Adler; J Rinaldi
Journal:  Am J Public Health       Date:  1999-07       Impact factor: 9.308

2.  Provision of drug treatment services in the juvenile justice system: a system reform.

Authors:  Y M Terry; C J VanderWaal; D C McBride; H Van Buren
Journal:  J Behav Health Serv Res       Date:  2000-05       Impact factor: 1.505

3.  The health and mental health of disabled substance abusers.

Authors:  K E Watkins; D Podus; E Lombardi
Journal:  J Behav Health Serv Res       Date:  2001-05       Impact factor: 1.505

4.  Substance abuse treatment management information systems: balancing federal, state, and service provider needs.

Authors:  J M Camp; M Krakow; D McCarty; M Argeriou
Journal:  J Ment Health Adm       Date:  1992

5.  Day versus inpatient treatment for cocaine dependence: an experimental comparison.

Authors:  R Schneider; C Mittelmeier; D Gadish
Journal:  J Ment Health Adm       Date:  1996

6.  Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up.

Authors:  David H Epstein; Wesley E Hawkins; Lino Covi; Annie Umbricht; Kenzie L Preston
Journal:  Psychol Addict Behav       Date:  2003-03

7.  CJDATS Co-Occurring Disorders Screening Instrument for Mental Disorders (CODSI-MD): A Pilot Study.

Authors:  Stanley Sacks; Gerald Melnick; Carrie Coen; Steven Banks; Peter D Friedmann; Christine Grella; Kevin Knight
Journal:  Prison J       Date:  2007-03

8.  Associations between Antisocial Personality Disorder and Sex on Discounting Rates.

Authors:  Leonardo F Andrade; Levi Riven; Nancy M Petry
Journal:  Psychol Rec       Date:  2014-12-01

9.  Abstinence-contingent reinforcement and engagement in non-drug-related activities among illicit drug abusers.

Authors:  Randall E Rogers; Stephen T Higgins; Kenneth Silverman; Colleen S Thomas; Gary J Badger; George Bigelow; Maxine Stitzer
Journal:  Psychol Addict Behav       Date:  2008-12

10.  Prospective trial of customized adherence enhancement plus long-acting injectable antipsychotic medication in homeless or recently homeless individuals with schizophrenia or schizoaffective disorder.

Authors:  Martha Sajatovic; Jennifer Levin; Luis F Ramirez; David Y Hahn; Curtis Tatsuoka; Christopher S Bialko; Kristin A Cassidy; Edna Fuentes-Casiano; Tiffany D Williams
Journal:  J Clin Psychiatry       Date:  2013-12       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.